| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
55,913 |
52,898 |
$3.95M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
82,116 |
78,791 |
$3.52M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
60,501 |
54,570 |
$1.71M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,856 |
22,551 |
$929K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,851 |
2,779 |
$624K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
70,611 |
64,198 |
$618K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
10,979 |
10,484 |
$575K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,858 |
1,759 |
$490K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,180 |
1,060 |
$298K |
| 80053 |
Comprehensive metabolic panel |
21,221 |
18,896 |
$272K |
| 64493 |
|
3,261 |
2,065 |
$253K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,050 |
4,945 |
$249K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,867 |
15,868 |
$231K |
| 86780 |
|
12,536 |
11,642 |
$212K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,602 |
4,226 |
$195K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
8,492 |
7,931 |
$191K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
7,752 |
7,247 |
$179K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21,817 |
20,103 |
$174K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,556 |
9,250 |
$160K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,394 |
3,215 |
$155K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12,877 |
11,893 |
$140K |
| 71046 |
Radiologic examination, chest; 2 views |
11,081 |
10,740 |
$136K |
| 88142 |
|
6,138 |
5,449 |
$135K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,651 |
2,819 |
$129K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
627 |
305 |
$108K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,334 |
6,167 |
$106K |
| 87581 |
|
2,851 |
2,778 |
$105K |
| 87486 |
|
2,851 |
2,778 |
$105K |
| 64483 |
|
1,122 |
1,007 |
$93K |
| 81003 |
|
30,816 |
29,044 |
$90K |
| 86762 |
|
4,659 |
4,392 |
$90K |
| 87070 |
|
6,957 |
6,769 |
$85K |
| 87340 |
|
6,297 |
5,829 |
$80K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
160 |
156 |
$72K |
| 81025 |
|
16,524 |
15,528 |
$54K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,849 |
3,373 |
$51K |
| 86803 |
|
3,307 |
3,041 |
$49K |
| 74018 |
|
4,358 |
4,190 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,822 |
2,656 |
$48K |
| 62323 |
|
733 |
710 |
$45K |
| 87081 |
|
4,455 |
4,191 |
$40K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,956 |
2,736 |
$39K |
| 86850 |
|
5,996 |
5,561 |
$37K |
| 76770 |
|
1,032 |
990 |
$34K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,679 |
347 |
$31K |
| 82950 |
|
4,594 |
4,439 |
$30K |
| 85045 |
|
5,061 |
4,299 |
$30K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,148 |
1,973 |
$29K |
| 0002A |
|
777 |
762 |
$27K |
| 82803 |
|
838 |
798 |
$27K |
| 27096 |
|
177 |
94 |
$27K |
| G0378 |
Hospital observation service, per hour |
367 |
328 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
264 |
257 |
$26K |
| 0001A |
|
1,018 |
857 |
$26K |
| 86696 |
|
1,434 |
1,329 |
$23K |
| 86695 |
|
1,431 |
1,326 |
$22K |
| 95816 |
|
650 |
613 |
$21K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
695 |
657 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
494 |
470 |
$20K |
| 83020 |
|
1,175 |
997 |
$18K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,885 |
8,367 |
$17K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
43 |
40 |
$17K |
| 86900 |
|
5,919 |
5,460 |
$17K |
| 86901 |
|
5,919 |
5,460 |
$17K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,003 |
389 |
$16K |
| 87400 |
|
2,680 |
2,230 |
$15K |
| 82728 |
|
1,146 |
1,043 |
$14K |
| 87077 |
|
1,706 |
1,488 |
$13K |
| 83615 |
|
2,097 |
1,796 |
$13K |
| 87420 |
|
807 |
795 |
$13K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
329 |
299 |
$11K |
| 83605 |
|
889 |
837 |
$11K |
| 84439 |
|
1,071 |
1,020 |
$10K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
391 |
371 |
$10K |
| 80061 |
Lipid panel |
551 |
534 |
$10K |
| 83550 |
|
747 |
694 |
$10K |
| 93296 |
|
962 |
940 |
$9K |
| 87088 |
|
851 |
783 |
$9K |
| 80076 |
|
1,464 |
1,369 |
$9K |
| 83655 |
|
516 |
496 |
$8K |
| 87210 |
|
1,360 |
1,288 |
$8K |
| 86140 |
|
3,295 |
3,184 |
$8K |
| 83735 |
|
835 |
661 |
$8K |
| 85014 |
|
2,453 |
2,299 |
$7K |
| 82330 |
|
820 |
789 |
$7K |
| 85018 |
|
2,202 |
2,105 |
$7K |
| 83540 |
|
784 |
729 |
$7K |
| 86694 |
|
429 |
402 |
$7K |
| 82731 |
|
84 |
79 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
587 |
572 |
$6K |
| 84100 |
|
1,134 |
896 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
142 |
139 |
$5K |
| 82553 |
|
497 |
392 |
$5K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
27 |
24 |
$5K |
| 83690 |
|
872 |
820 |
$5K |
| 85610 |
|
1,139 |
853 |
$5K |
| 84484 |
|
781 |
534 |
$5K |
| 62264 |
|
70 |
70 |
$5K |
| 82607 |
|
234 |
230 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
168 |
76 |
$5K |
| 0071A |
|
130 |
128 |
$5K |
| 82947 |
|
1,261 |
1,204 |
$5K |
| 84702 |
|
362 |
328 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
230 |
145 |
$4K |
| 0072A |
|
140 |
126 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,373 |
5,158 |
$4K |
| 64490 |
|
52 |
36 |
$4K |
| 0004A |
|
97 |
96 |
$4K |
| 82550 |
|
532 |
418 |
$3K |
| 85027 |
|
606 |
575 |
$3K |
| 59025 |
Fetal non-stress test |
631 |
582 |
$3K |
| 84481 |
|
165 |
161 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
15 |
15 |
$3K |
| 87040 |
|
210 |
205 |
$2K |
| 93880 |
|
50 |
37 |
$2K |
| 84550 |
|
306 |
282 |
$2K |
| 62370 |
|
28 |
24 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
16 |
12 |
$2K |
| 83021 |
|
107 |
92 |
$2K |
| 84144 |
|
93 |
90 |
$1K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
245 |
237 |
$1K |
| 87186 |
|
126 |
110 |
$1K |
| 86738 |
|
61 |
58 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
84 |
70 |
$1K |
| 62321 |
|
12 |
12 |
$976.71 |
| 76801 |
|
39 |
36 |
$943.60 |
| 62369 |
|
12 |
12 |
$871.56 |
| 71045 |
Radiologic examination, chest; single view |
323 |
292 |
$865.39 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,093 |
981 |
$846.82 |
| 83516 |
|
188 |
145 |
$844.24 |
| 82670 |
|
27 |
26 |
$834.73 |
| 85660 |
|
172 |
159 |
$803.82 |
| 82570 |
|
131 |
123 |
$786.24 |
| 85730 |
|
433 |
392 |
$752.74 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
13 |
13 |
$688.72 |
| 84295 |
|
230 |
208 |
$661.78 |
| 84132 |
|
228 |
208 |
$661.78 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
822 |
755 |
$644.97 |
| 90686 |
|
46 |
39 |
$608.96 |
| 82784 |
|
151 |
145 |
$589.56 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,079 |
5,705 |
$579.92 |
| 84681 |
|
44 |
39 |
$579.80 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,738 |
1,247 |
$573.18 |
| 84156 |
|
131 |
123 |
$525.33 |
| 84466 |
|
16 |
16 |
$372.60 |
| J2704 |
Injection, propofol, 10 mg |
10,753 |
9,928 |
$272.58 |
| 85652 |
|
69 |
61 |
$251.21 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
6,346 |
5,916 |
$206.74 |
| 74019 |
|
12 |
12 |
$197.23 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
365 |
337 |
$183.77 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
210 |
164 |
$138.68 |
| 82248 |
|
29 |
26 |
$133.90 |
| 82247 |
|
29 |
26 |
$126.10 |
| 80069 |
|
15 |
13 |
$115.57 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
391 |
344 |
$109.68 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
85 |
82 |
$96.93 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
792 |
776 |
$92.05 |
| 82565 |
|
39 |
39 |
$75.31 |
| J1644 |
Injection, heparin sodium, per 1000 units |
468 |
228 |
$73.20 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
580 |
483 |
$71.93 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
121 |
79 |
$68.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,114 |
1,805 |
$65.24 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
67 |
66 |
$50.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
146 |
136 |
$49.90 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,366 |
1,278 |
$43.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,495 |
3,292 |
$37.09 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,678 |
10,960 |
$36.83 |
| 82962 |
|
1,077 |
991 |
$34.67 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$24.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
508 |
417 |
$20.30 |
| 82435 |
|
14 |
14 |
$16.77 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
510 |
495 |
$11.21 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
1,097 |
1,022 |
$10.59 |
| 88304 |
|
98 |
87 |
$8.53 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
65 |
64 |
$0.77 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
105 |
94 |
$0.06 |
| 64491 |
|
52 |
36 |
$0.00 |
| 64495 |
|
2,465 |
1,637 |
$0.00 |
| 82948 |
|
101 |
26 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
18 |
14 |
$0.00 |
| 69210 |
|
18 |
14 |
$0.00 |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
13 |
13 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
59 |
40 |
$0.00 |
| 64494 |
|
2,789 |
1,890 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
296 |
283 |
$0.00 |
| 81511 |
|
1,067 |
1,020 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
186 |
184 |
$0.00 |
| J1597 |
Injection, glycopyrrolate (glyrx-pf), 0.1 mg |
12 |
12 |
$0.00 |
| 88342 |
|
35 |
33 |
$0.00 |
| 64492 |
|
17 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
29 |
14 |
$0.00 |